Alto Neuroscience (ANRO) Earnings Date & Reports

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individualsâ€™ neurobiology to develop personalized and effective treatment options... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANRO is expected to report earnings to rise 9.62% to -56 cents per share on May 20

Alto Neuroscience ANRO Stock Earnings Reports

Q1'25

Est.

$-0.57

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.06

Q2'24

Missed

by $0.07

The last earnings report on March 20 showed earnings per share of -51 cents, beating the estimate of -55 cents. With 483.84K shares outstanding, the current market capitalization sits at 48.73M.

View a ticker or compare two or three

Compare

ANRO